Roland Griffiths

School of Medicine Johns Hopkins University, Baltimore, MD 
Behavioral Pharmacology
"Roland Griffiths"
Mean distance: 15.22 (cluster 23)


Sign in to add trainee
John D.Roache grad student Johns Hopkins Medical School (PsychTree)
Lawrence P. Carter post-doc Johns Hopkins
Thomas S. Critchfield post-doc Johns Hopkins (PsychTree)
Matthew Johnson post-doc Johns Hopkins (PsychTree)
R J. Lamb post-doc Johns Hopkins
Katherine A. MacLean post-doc Johns Hopkins
Chad J. Reissig post-doc Johns Hopkins
Mary M Sweeney post-doc Johns Hopkins School of Medcine (PsychTree)
Frederick Streeter Barrett post-doc 2013- Johns Hopkins Medical School
Manoj K. Doss post-doc 2018- Johns Hopkins Medical School
Jack E. Henningfield post-doc 1978-1980 Johns Hopkins
Scott E. Lukas post-doc 1979-1982 Johns Hopkins
Stephen T. Higgins post-doc 1983-1985 Johns Hopkins
Warren K. Bickel post-doc 1984-1985 Johns Hopkins
Martin Iguchi post-doc 1986-1988 Johns Hopkins
Kenneth Silverman post-doc 1989-1991 Johns Hopkins
Elise Weerts post-doc 1993-1995
Thomas Eissenberg post-doc 1994-1996
Miriam Z. Mintzer post-doc 1995-1998 Johns Hopkins
Laura M. Juliano post-doc 2001-2002 American University (PsychTree)
Laura M. Juliano post-doc 2001-2002 American University (PsychTree)
Stacey C. Sigmon post-doc 2002-2004 Johns Hopkins (PsychTree)
Steven  E. Meredith post-doc 2012-2014 Johns Hopkins
Albert P. Garcia-Romeu post-doc 2012-2016 Johns Hopkins (PsychTree)
Albert P. Garcia-Romeu post-doc 2012-2016 Johns Hopkins (PsychTree)
Theresa Carbonaro post-doc 2013-2016
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sweeney MM, Meredith SE, Juliano LM, et al. (2018) A randomized controlled trial of a manual-only treatment for reduction and cessation of problematic caffeine use. Drug and Alcohol Dependence. 195: 45-51
Johnson MW, Hendricks PS, Barrett FS, et al. (2018) Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics. Pharmacology & Therapeutics
Barrett FS, Carbonaro TM, Hurwitz E, et al. (2018) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology
Noorani T, Garcia-Romeu A, Swift TC, et al. (2018) Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology (Oxford, England). 269881118780612
Johnson MW, Griffiths RR, Hendricks PS, et al. (2018) The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology
Carbonaro TM, Johnson MW, Hurwitz E, et al. (2017) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology
Griffiths RR, Johnson MW, Richards WA, et al. (2017) Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England). 269881117731279
Barrett FS, Robbins H, Smooke D, et al. (2017) Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions. Frontiers in Psychology. 8: 1238
Barrett FS, Johnson MW, Griffiths RR. (2017) Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences. 117: 155-160
Johnson MW, Griffiths RR. (2017) Potential Therapeutic Effects of Psilocybin. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
See more...